← Leaderboards
Erez Eitan
Neurodex Inc
$6,029,315
Attributed
$7,529,335
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,529,335 · 4
By mechanism
R44$5,067,005 · 2
R24$2,250,030 · 1
R43$212,300 · 1
Top collaborators
- David W Craig1 shared
- Xianjun Dong1 shared
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposBrainPlasmaSpecificityBiological MarkersSmall Business Innovation Research GrantPathologyNerve DegenerationDiagnostic AssayNeuronsBloodExtracellular VesiclesSamplingS DiseaseBiomarker DiscoveryNeurodegenerative DisordersClinical TrialsDrug DevelopmentDiagnosisDetectionDiagnosticCellsPatient StratificationStratification
Grant awards (7)
Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia$518,202
R44 · FY2025 · NS · contact PI
Blood-based Biomarker for Characterizing Progression and Therapeutic Response in Amyotrophic Lateral Sclerosis$2,147,016
R44 · FY2024 · NS · contact PI
Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia$942,163
R44 · FY2024 · NS · contact PI
A Large-scale Extracellular Vesicle RNA-seq Resource for Parkinsons Disease$2,250,030
R24 · FY2023 · NS
Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia$1,009,625
R44 · FY2023 · NS · contact PI
Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia$449,999
R44 · FY2022 · NS · contact PI
Presymptomatic Diagnostic Tools for Alzheimers Disease by Blood Neuron Derived Exosome Analysis$212,300
R43 · FY2019 · AG · contact PI